Coronavirus: New inhaled vaccine gets emergency use approval in China

CanSino Biologics Inc's inhaled version of its adenovirus-vectored Covid-19 vaccine has been approved by China's medical products regulator for emergency use as a booster, the company said in a filing on Sunday.

• Triple threat: Italian man tests positive for monkeypox, Covid-19 and HIV at the same time